{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:27:38Z","timestamp":1789140458115,"version":"build-2803163510"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.neuroscience.2016.10.070","type":"journal-article","created":{"date-parts":[[2016,11,6]],"date-time":"2016-11-06T00:01:47Z","timestamp":1478390507000},"page":"308-318","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["The significance of rotational behavior and sensitivity of striatal dopamine receptors in hemiparkinsonian rats: A comparative study of lactacystin and 6-OHDA"],"prefix":"10.1016","volume":"340","author":[{"given":"Jolanta","family":"Konieczny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Czarnecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Lenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinga","family":"Kami\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucyna","family":"Antkiewicz-Michaluk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2016.10.070_b0005","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0014-2999(86)90573-X","article-title":"1-Methyl-4-phenylpyridine (MPP+): regional dopamine neuron uptake, toxicity, and novel rotational behavior following dopamine receptor proliferation","volume":"131","author":"Altar","year":"1986","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0010","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3389\/fnbeh.2015.00068","article-title":"Nigral proteasome inhibition in mice leads to motor and non-motor deficits and increased expression of Ser129 phosphorylated \u03b1-synuclein","volume":"9","author":"Bentea","year":"2015","journal-title":"Front Behav Neurosci"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0015","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/mds.25108","article-title":"Animal models of Parkinson\u2019s disease: limits and relevance to neuroprotection studies","volume":"28","author":"Bezard","year":"2013","journal-title":"Mov Disord"},{"issue":"Suppl 2","key":"10.1016\/j.neuroscience.2016.10.070_b0020","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.parkreldis.2008.04.015","article-title":"The 6-hydroxydopamine model: news from the past","volume":"14","author":"Blandini","year":"2008","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0025","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s002590050374","article-title":"Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonism","volume":"26","author":"Booij","year":"1999","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0030","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","article-title":"Stages in the development of Parkinson\u2019s disease-related pathology","volume":"318","author":"Braak","year":"2004","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0035","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/ana.410310209","article-title":"Striatal D2 receptor status in patients with Parkinson\u2019s disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography","volume":"31","author":"Brooks","year":"1992","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0040","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0006-8993(91)90835-J","article-title":"Partial lesion of the substantia nigra: relation between extent of lesion and rotational behavior","volume":"553","author":"Carman","year":"1991","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0045","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.brainres.2015.12.036","article-title":"Chronic low-dose melatonin treatment maintains nigrostriatal integrity in an intrastriatal rotenone model of Parkinson\u2019s disease","volume":"1633","author":"Carriere","year":"2016","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0050","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0006-8993(76)90843-X","article-title":"The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain","volume":"118","author":"Costall","year":"1976","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0055","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.bbr.2008.01.012","article-title":"Hemiparkinsonian rats rotate toward the side with the weaker dopaminergic neurotransmission","volume":"189","author":"Da Cunha","year":"2008","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0060","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF00236638","article-title":"Lesions of the globus pallidus, entopeduncular nucleus and substantia nigra alter dopamine mediated circling behaviour","volume":"52","author":"Dewar","year":"1983","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0065","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF00498985","article-title":"Substantia nigra as an out-put station for striatal dopaminergic responses: role of a GABA-mediated inhibition of pars reticulata neurons","volume":"306","author":"Di Chiara","year":"1979","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0070","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1476-5381.2011.01426.x","article-title":"Animal models of Parkinson\u2019s disease: a source of novel treatments and clues to the cause of the disease","volume":"164","author":"Duty","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0075","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1007\/BF01485901","article-title":"Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system","volume":"38","author":"Ehringer","year":"1960","journal-title":"Klin Wochenschr"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0080","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0006-8993(94)91872-4","article-title":"The effects of chronic continuous versus intermittent levodopa treatments on striatal and extrastriatal D1 and D2 dopamine receptors and dopamine uptake sites in the 6-hydroxydopamine lesioned rat - an autoradiographic study","volume":"640","author":"Gnanalingham","year":"1994","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0085","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0006-8993(90)90440-M","article-title":"Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. II. Unilateral intra-carotid infusion of MPTP in the monkey (Macaca fascicularis)","volume":"514","author":"Graham","year":"1990","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0090","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0006-8993(90)90439-I","article-title":"Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. I. 6-OHDA lesions of ascending mesencephalic dopaminergic pathways in the rat","volume":"514","author":"Graham","year":"1990","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0095","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0733-8619(18)30216-0","article-title":"Dopamine receptors in Parkinson\u2019s disease","volume":"10","author":"Guttman","year":"1992","journal-title":"Neurol Clin"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0100","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0091-3057(80)90353-6","article-title":"Circling behavior in rats with partial, unilateral nigro-striatal lesions: effect of amphetamine, apomorphine, and DOPA","volume":"12","author":"Hefti","year":"1980","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0105","first-page":"954","article-title":"Loss of dopamine-D2 receptor binding sites in Parkinsonian plus syndromes","volume":"39","author":"Hierholzer","year":"1998","journal-title":"J Nucl Med"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0110","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0014-2999(86)90517-0","article-title":"The dopamine autoreceptor agonist B-HT 920 stimulates denervated postsynaptic brain dopamine receptors in rodent and primate models of Parkinson\u2019s disease: a novel approach to treatment","volume":"131","author":"Hinzen","year":"1986","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0115","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0006-8993(93)90576-9","article-title":"Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats","volume":"626","author":"Hudson","year":"1993","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0120","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0014-2999(76)90042-X","article-title":"Circling behavior in rats with 6-hydroxydopamine or electrolytic nigral lesions","volume":"37","author":"Iwamoto","year":"1976","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0125","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1006\/neur.1995.0016","article-title":"6-Hydroxydopamine lesion of the rat substantia nigra: time course and morphology of cell death","volume":"4","author":"Jeon","year":"1995","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0130","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0531-5131(03)01573-5","article-title":"Hemiparkinsonian rat models: different sensitivity of dopaminergic neurotoxins","volume":"1260","author":"Kondo","year":"2004","journal-title":"Int Congr Ser"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0135","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bbr.2013.12.019","article-title":"Chronic L-DOPA treatment attenuates behavioral and biochemical deficits induced by unilateral lactacystin administration into the rat substantia nigra","volume":"261","author":"Konieczny","year":"2014","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0140","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.bbr.2015.01.043","article-title":"Decreased behavioral response to intranigrally administered GABAA agonist muscimol in the lactacystin model of Parkinson\u2019s disease may result from partial lesion of nigral non-dopamine neurons: comparison to the classical neurotoxin 6-OHDA","volume":"283","author":"Konieczny","year":"2015","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0145","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.neuroscience.2016.02.072","article-title":"Early increase in dopamine release in the ipsilateral striatum after unilateral intranigral administration of lactacystin produces spontaneous contralateral rotations in rats","volume":"324","author":"Konieczny","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0150","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0166-4328(90)90178-H","article-title":"Nigral D1 and striatal D2 receptors mediate the behavioral effects of dopamine agonists","volume":"38","author":"LaHoste","year":"1990","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0155","first-page":"21","article-title":"Modification by apomorphine of the circling behaviour in the rat due to unilateral intranigral injection of 1-methyl-4-phenylpyridine (MPP+)","volume":"9","author":"Lange","year":"1989","journal-title":"J Toxicol Clin Exp"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0160","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/0306-4522(95)00571-4","article-title":"Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by instrastriatal 6-hydroxydopamine in the rat","volume":"72","author":"Lee","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0165","series-title":"Handbuch der Neurologie","first-page":"920","article-title":"Paralysis agitans. I. Pathologische anatomic","author":"Lewy","year":"1912"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0170","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/taap.1996.0054","article-title":"Effects of paraquat on the substantia nigra of the Wistar rats: neurochemical, histological, and behavioral studies","volume":"137","author":"Liou","year":"1996","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0175","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.neuint.2011.03.013","article-title":"Different effects of intranigral and intrastriatal administration of the proteasome inhibitor lactacystin on typical neurochemical and histological markers of Parkinson\u2019s disease in rats","volume":"58","author":"Lorenc-Koci","year":"2011","journal-title":"Neurochem Int"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0180","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0185","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.expneurol.2013.03.021","article-title":"Direct intranigral administration of an ubiquitin proteasome system inhibitor in rat: behavior, positron emission tomography, immunohistochemistry","volume":"247","author":"Mackey","year":"2013","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0190","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1097\/00001756-200208070-00018","article-title":"Proteasome inhibition causes nigral degeneration with inclusion bodies in rats","volume":"13","author":"McNaught","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0195","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/syn.21883","article-title":"Interpreting DTBZ binding data in rodent: Inherent variability and compensation","volume":"70","author":"Mejias","year":"2016","journal-title":"Synapse"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0200","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1523\/JNEUROSCI.12-10-03729.1992","article-title":"D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson\u2019s disease","volume":"12","author":"Paul","year":"1992","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0205","series-title":"The rat brain in stereotaxic coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0210","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00429-013-0669-5","article-title":"An animal model mimicking pedunculopontine nucleus cholinergic degeneration in Parkinson\u2019s disease","volume":"220","author":"Pienaar","year":"2015","journal-title":"Brain Struct Funct"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0215","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0306-4522(80)90048-2","article-title":"Turning behaviour in animals","volume":"5","author":"Pycock","year":"1980","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0220","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/mds.870050114","article-title":"Positron emission tomography demonstrates dopamine D2 receptor supersensitivity in the striatum of patients with early Parkinson\u2019s disease","volume":"5","author":"Rinne","year":"1990","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-2952(75)90304-4","article-title":"Mechanisms of action of 6-hydroxydopamine","volume":"24","author":"Sachs","year":"1975","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0230","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0301-0082(96)00040-8","article-title":"The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments","volume":"50","author":"Schwarting","year":"1996","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0235","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0301-0082(96)00015-9","article-title":"Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae","volume":"49","author":"Schwarting","year":"1996","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0240","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.brainres.2005.05.051","article-title":"Behavioral differences in a rotenone-induced hemiparkinsonian rat model developed following intranigral or median forebrain bundle infusion","volume":"1051","author":"Sindhu","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0245","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.pbb.2006.05.017","article-title":"Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine","volume":"84","author":"Sindhu","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0250","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0022-3565(25)19992-8","article-title":"Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway","volume":"247","author":"Sonsalla","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0255","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","article-title":"Alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with Lewy bodies","volume":"95","author":"Spillantini","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0260","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF01245141","article-title":"Neurotoxic damage to the nigrostriatal system in rats following intranigral administration of MPDP+ and MPP+","volume":"74","author":"Sun","year":"1988","journal-title":"J Neural Transm"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0265","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1212\/WNL.49.3.717","article-title":"In vivo studies on striatal dopamine D1 and D2 site binding in L-dopa-treated Parkinson\u2019s disease patients with and without dyskinesias","volume":"49","author":"Turjanski","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0270","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-201X.1971.tb10999.x","article-title":"Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour","volume":"367","author":"Ungerstedt","year":"1971","journal-title":"Acta Physiol Scand Suppl"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2202-11-1","article-title":"Non-invasive evaluation of nigrostriatal neuropathology in a proteasome inhibitor rodent model of Parkinson\u2019s disease","volume":"11","author":"Vernon","year":"2010","journal-title":"BMC Neurosci"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0280","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1471-4159.2010.06914.x","article-title":"Proteasome inhibition modeling nigral neuron degeneration in Parkinson\u2019s disease","volume":"115","author":"Xie","year":"2010","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2016.10.070_b0285","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neuro.2015.09.009","article-title":"Protective effects of Forsythia suspense extract with antioxidant and anti-inflammatory properties in a model of rotenone induced neurotoxicity","volume":"52","author":"Zhang","year":"2016","journal-title":"Neurotoxicology"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030645221630611X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030645221630611X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T01:05:43Z","timestamp":1749690343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030645221630611X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":57,"alternative-id":["S030645221630611X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2016.10.070","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}